Uipath [PATH] vs Amdocs [DOX] Detailed Stock Comparison
Uipath
NYSE
Loading...
Amdocs
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Uipath wins in 4 metrics, Amdocs wins in 14 metrics, with 0 ties. Amdocs appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Uipath | Amdocs | Better |
|---|---|---|---|
| P/E Ratio (TTM) | -83.65 | 17.53 | Uipath |
| Price-to-Book Ratio | 3.46 | 2.72 | Amdocs |
| Debt-to-Equity Ratio | 4.65 | 23.65 | Uipath |
| PEG Ratio | 4.18 | 1.26 | Amdocs |
| EV/EBITDA | -50.80 | 10.13 | Uipath |
| Profit Margin (TTM) | -4.65% | 11.94% | Amdocs |
| Operating Margin (TTM) | -3.76% | 17.69% | Amdocs |
| EBITDA Margin (TTM) | N/A | 17.69% | N/A |
| Return on Equity | -3.62% | 15.73% | Amdocs |
| Return on Assets (TTM) | -2.32% | 7.87% | Amdocs |
| Free Cash Flow (TTM) | $305.64M | $618.93M | Amdocs |
| 1-Year Return | -9.99% | 3.32% | Amdocs |
| Price-to-Sales Ratio (TTM) | 4.05 | 2.05 | Amdocs |
| Enterprise Value | $4.50B | $10.06B | Amdocs |
| EV/Revenue Ratio | 3.10 | 2.17 | Amdocs |
| Gross Profit Margin (TTM) | 82.09% | 37.86% | Uipath |
| Revenue per Share (TTM) | $3 | $41 | Amdocs |
| Earnings per Share (Diluted) | $-0.12 | $4.94 | Amdocs |
| Beta (Stock Volatility) | 1.03 | 0.52 | Amdocs |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Uipath vs Amdocs Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Uipath | 2.57% | 1.92% | -11.28% | -9.48% | -15.63% | -13.61% |
| Amdocs | 1.92% | 1.04% | -1.35% | -3.66% | -0.05% | 4.88% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Uipath | -9.99% | -34.10% | -85.07% | -85.07% | -85.07% | -85.07% |
| Amdocs | 3.32% | 2.25% | 45.11% | 53.06% | 235.24% | 210.59% |
Performance & Financial Health Analysis: Uipath vs Amdocs
| Metric | PATH | DOX |
|---|---|---|
| Market Information | ||
| Market Cap | $5.88B | $9.53B |
| Market Cap Category | Mid cap | Mid cap |
| 10 Day Avg. Volume | 10,202,737 | 885,940 |
| 90 Day Avg. Volume | 12,737,896 | 825,317 |
| Last Close | $11.17 | $88.27 |
| 52 Week Range | $9.38 - $15.93 | $78.61 - $95.41 |
| % from 52W High | -29.88% | -7.48% |
| All-Time High | $90.00 (May 24, 2021) | $99.75 (Jun 26, 2023) |
| % from All-Time High | -87.59% | -11.51% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.06% | -0.08% |
| Quarterly Earnings Growth | 0.06% | 0.10% |
| Financial Health | ||
| Profit Margin (TTM) | -0.05% | 0.12% |
| Operating Margin (TTM) | -0.04% | 0.18% |
| Return on Equity (TTM) | -0.04% | 0.16% |
| Debt to Equity (MRQ) | 4.65 | 23.65 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $3.18 | $31.85 |
| Cash per Share (MRQ) | $2.91 | $3.11 |
| Operating Cash Flow (TTM) | $339.53M | $737.18M |
| Levered Free Cash Flow (TTM) | $471.82M | $563.54M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Uipath vs Amdocs
| Metric | PATH | DOX |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | -83.65 | 17.53 |
| Forward P/E | 24.98 | 12.32 |
| PEG Ratio | 4.18 | 1.26 |
| Price to Sales (TTM) | 4.05 | 2.05 |
| Price to Book (MRQ) | 3.46 | 2.72 |
| Market Capitalization | ||
| Market Capitalization | $5.88B | $9.53B |
| Enterprise Value | $4.50B | $10.06B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 3.10 | 2.17 |
| Enterprise to EBITDA | -50.80 | 10.13 |
| Risk & Other Metrics | ||
| Beta | 1.03 | 0.52 |
| Book Value per Share (MRQ) | $3.18 | $31.85 |
Financial Statements Comparison: Uipath vs Amdocs
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | PATH | DOX |
|---|---|---|
| Revenue/Sales | $356.62M | $1.13B |
| Cost of Goods Sold | $63.86M | $698.05M |
| Gross Profit | $292.77M | $430.15M |
| Research & Development | $94.84M | $81.80M |
| Operating Income (EBIT) | $-16.41M | $197.74M |
| EBITDA | $-13.16M | $244.14M |
| Pre-Tax Income | $-19.73M | $189.27M |
| Income Tax | $2.83M | $25.27M |
| Net Income (Profit) | $-22.56M | $164.00M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | PATH | DOX |
|---|---|---|
| Cash & Equivalents | $700.64M | $247.39M |
| Total Current Assets | $2.11B | $1.56B |
| Total Current Liabilities | $715.87M | $1.34B |
| Long-Term Debt | $73.43M | $748.93M |
| Total Shareholders Equity | $1.70B | $3.50B |
| Retained Earnings | $-2.01B | N/A |
| Property, Plant & Equipment | $66.98M | $874.85M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | PATH | DOX |
|---|---|---|
| Operating Cash Flow | $195.89M | $195.07M |
| Capital Expenditures | $-12.83M | $-15.96M |
| Free Cash Flow | $106.17M | $156.49M |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | $-227.53M | $-135.24M |
Short Interest & Institutional Ownership Analysis
| Metric | PATH | DOX |
|---|---|---|
| Shares Short | 54.95M | 4.39M |
| Short Ratio | 4.37 | 6.52 |
| Short % of Float | 0.15% | 0.05% |
| Average Daily Volume (10 Day) | 10,202,737 | 885,940 |
| Average Daily Volume (90 Day) | 12,737,896 | 825,317 |
| Shares Outstanding | 553.51M | 112.89M |
| Float Shares | 422.75M | 107.76M |
| % Held by Insiders | 0.08% | 0.00% |
| % Held by Institutions | 0.82% | 0.99% |
Dividend Analysis & Yield Comparison: Uipath vs Amdocs
| Metric | PATH | DOX |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |